A system to estimate relapse-free survival probabilities and probable benefit from adjuvant therapy in patients with operable breast cancer.

被引：0
|
作者：
Miles, DW
Ryder, K
Rubens, RD
Royston, P
机构：
[1] Guys Hosp, London SE1 9RT, England
[2] MRC, Clin Trials Unit, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [21] RELAPSE-FREE SURVIVAL IN BREAST-CANCER PATIENTS - THE IMPORTANCE OF THE PRESENCE OF PROGESTERONE RECEPTORS FOR PROGNOSIS
    ZIELINSKI, CC
    KUZMITS, R
    SPONA, J
    SALZER, H
    KUBISTA, E
    STAFFEN, A
    AIGINGER, P
    BLUT, 1984, 49 (03): : 243 - 243
  • [22] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Ming-Feng Hou
    Po-Ming Chen
    Pei-Yi Chu
    BMC Cancer, 18
  • [23] Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
    Christopher M. Gallagher
    Kenneth More
    Tripthi Kamath
    Anthony Masaquel
    Annie Guerin
    Raluca Ionescu-Ittu
    Marjolaine Gauthier-Loiselle
    Roy Nitulescu
    Nicholas Sicignano
    Elizabeth Butts
    Eric Q. Wu
    Brian Barnett
    Breast Cancer Research and Treatment, 2016, 157 : 145 - 156
  • [24] Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
    Gallagher, Christopher M.
    More, Kenneth
    Kamath, Tripthi
    Masaquel, Anthony
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Gauthier-Loiselle, Marjolaine
    Nitulescu, Roy
    Sicignano, Nicholas
    Butts, Elizabeth
    Wu, Eric Q.
    Barnett, Brian
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (01) : 145 - 156
  • [25] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xionan
    Lin, Juan
    Condeelis, John S.
    Sparanno, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    CANCER RESEARCH, 2018, 78 (04)
  • [26] Concomitant radiation therapy does not affect adjuvant CMF delivery in patients with operable breast cancer.
    Montemurro, F
    Gatti, M
    Faggiuolo, R
    Durando, A
    Choa, G
    Piccinno, R
    Redana, S
    Sismondi, P
    Gabriele, P
    Aglietta, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 75S - 75S
  • [27] Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients
    Trilla-Fuertes, Lucia
    Gamez-Pozo, Angelo
    Diaz-Almiron, Mariana
    Prado-Vazquez, Guillermo
    Zapater-Moros, Andrea
    Lopez-Vacas, Rocio
    Nanni, Paolo
    Zamora, Pilar
    Espinosa, Enrique
    Fresno Vara, Juan Angel
    FUTURE ONCOLOGY, 2019, 15 (30) : 3483 - 3490
  • [28] Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors
    Coart, Elisabeth
    Suciu, Stefan
    Squifflet, Pierre
    Saad, Everardo D.
    Moshyk, Andriy
    de Schaetzen, Gaetan
    Buyse, Marc
    Weber, Jeffrey S.
    Eggermont, Alexander
    Kotapati, Srividya
    EUROPEAN JOURNAL OF CANCER, 2020, 137 : 171 - 174
  • [29] Occupational risk factors for relapse-free survival in bladder cancer patients
    Selinski, Silvia
    Buerger, Hannah
    Blaszkewicz, Meinolf
    Otto, Thomas
    Volkert, Frank
    Moormann, Oliver
    Niedner, Hartmut
    Hengstler, Jan G.
    Golka, Klaus
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2016, 79 (22-23): : 1136 - 1143
  • [30] Worse event-free and relapse-free survival in financially disadvantaged patients with breast cancer in South India
    Thumsi, J.
    Nataraj, M.
    Kavitha, M. L.
    Jadhav, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S80 - S81
12345